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Abstract 
Lung cancer is a leading cause of cancer death worldwide, causing 
approximately 1.2 million deaths per year. Lung cancer is prevalent in 
smokers. It is documented that smoking induces oxidative stress, which is 
thought to be associated with the aetiology of carcinogenesis. A case control 
cross sectional study was conducted on sixty lung cancer patients and sixty 
smokers as cohort control. Serum levels of antioxidant vitamin E, C and A 
among the case and control subjects were estimated. It was observed that 
vitamin E value among the study population did not alter (15.67±3.67µmol/L 
vs. 14.66±3.88µmol/L). It was within normal range. Conversely, there was 
significantly high serum concentrations of vitamin C and A in the lung 
cancer patients as compared to those in the smoker controls 
(48.26±6.81versus 16.65±4.46µmol/L; 2.76±0.32 versus 1.60±0.35µmol/L 
respectively).  
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Introduction 
Lung cancer is the leading cancer in male comprising 17% of the 
total new cancer cases and 23% of the total cancer deaths in the world (Jemal 
et al., 2011). In Bangladesh it is also the most common cancer of males 
(Akhtar et el., 2011).  Epidemiologic evidence indicates that diets high in 
carotenoid-rich fruits and vegetables, as well as high serum levels of vitamin 
E  and beta carotene, are associated with a reduced risk of lung cancer (The 
Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, Lee 
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et al., 2003, Padayatty et al., 2006). However, several large scale studies 
with intervention of β-carotene alone or combination of β-carotene and α-
tocopherol unexpectedly could not demonstrate prevention of lung or breast 
cancer (Lotan, 1999, Albanes, 1999).  Even some study concluded that 
intake of β-carotene or α-tocopherol may increase the risk of lung cancer in 
the smokers (Lotan, 1999, Edelson, 2008).  However, there is overwhelming 
evidence that a high intake of vitamin C correlates with a low risk for cancer. 
Vitamin C helps prevention and protection of cancer incidence, even mega 
doses of vitamin C could cure cancer (Ocké et al., 1997, Padayatty et al., 
2006, Hickey et al., 2008). The present study has attempted to address the 
serum vitamin E, C and A level in lung cancer patients in comparison with 
those in the smokers. 
 
Materials and Methods 
Study population 
It is case control cross sectional study conducted on sixty lung cancer 
patients and sixty smokers as cohort controls of age between 40 to 60 years. 
The hospitalized lung cancer patients were randomly selected from Dhaka 
medical college hospital, Mitford hospital, Cancer institute and some clinics 
in Dhaka city. Patients were histologically diagnosed and on routine 
treatment and dietary supplementation with vitamin C. Age and 
socioeconomic matched smokers smoking 15 or more cigarette sticks/day for 
a period of 10-15 years or >15 years were purposively enrolled as cohort 
control from the community. Patients were in medication and dietary 
supplementation. Blood specimens was collected from each of the patients 
and control subjects  
 
Serum analysis for estimation of vitamin E, A and C 
A 5ml of venous blood sample was collected from antecubital vein 
from each of the patients and control subjects for analysis of vitamin E, C 
and A. Serum was extracted from the blood by keeping it undisturbed for 60 
minutes and then centrifuged at 3000 rpm for 10 minutes. A reversed-phased 
HPLC (LC-10AD, Shimadzu, HPLC 1991, model-1725, Japan) was 
employed for simultaneous determination of vitamin E and A as describe by 
Islam et al (2001). The analytes vitamin E and A in the sera were isolated by 
liquid-liquid extraction using n-hexane and ethanol, which was concentrated 
by evaporation under nitrogen.  A 50µl reconstituted analyte was injected 
into chromatography on a C18 shim pack CLC-ODS (M) column of diameter 
4.6mm (Shimadzu, LC column, 4.6x250mm, no. 1256168, Japan) with 
methanol:water (95:5 ratio) mobile phase flowing at 1ml/min, detector set at 
one attenuation. Every sample was injected twice to obtain replicate 
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chromatographs.  Standard analytes were injected for every 25 test samples. 
Vitamin E and A were detected spectrophotometrically at 291nm.  
For vitamin C analysis, serum immediately after extraction from 
blood was treated with 5% trichloroacetic acid and centrifuged at 3000 rpm 
for 10 minutes. It was then treated phenyl hydrazine and absorbance was 
read against a reagent blank at 520nm in a Spectrophotometer (UV-1201, 
UV-vis, Shimadzu, Japan as describe by Islam et al (2001).  Every sample 
was analyzed twice to obtain replicate readings. Standards (retinol, α-
tocopherol, retinol acetate and α-tocopheryl acetate, ascorbic acid) were 
purchased from Sigma Chemical Co., USA and solvents (HPLC grade) were 
from Merck (Darmstadt, Germany).  
 
Statistical analysis 
The SPSS software package (12.5 SPSS version Inc. Chicago USA) 
was used for statistical analysis. Data were presented as mean±sd. 
Comparison of serum vitamin levels between groups was performed by 
student’s t test. P<0.05 was considered as a level of significance. 
 
Results and Discussion 
Table 1 shows serum concentrations of vitamin E, C and A in the 
lung cancer patients and healthy smokers as control subjects.  Vitamin E 
value among the study population was found to be within normal range 
(Young, 1998). Although it was higher in the lung cancer patients (15.67 ± 
3.67µmol/L) than that in the smokers (14.66 ± 3.88µmol/L), the difference 
was insignificant. In case of vitamin C, it was significantly (p=0.000) high 
(48.26 ± 6.81µmol/L) in the lung cancer patients as compared to that in the 
smokers (48.26 ± 6.81versus 16.65 ± 4.46µmol/L; p=0.000). Lung cancer 
patients had have significantly (p=0.000) higher serum vitamin A level than 
that in the smokers (2.76 ± 0.32 versus 1.60 ± 0.35µmol/L).   
Table 1: Serum vitamin E, C and A level in lung cancer patient and smoker control 
*value expressed as mean ± SD 
student’s t test: p<0.05  as level of significance 
 
Lung cancer is a leading cause of cancer death worldwide, causing 
approximately 1.2 million deaths per year (van der Meij et al.,2012). 
Oxidative stress is thought to be associated with the etiology of 
carcinogenesis (Klaunig and Kamendulis, 2004, Toyokuni, 2006). Smoking 
induces oxidative stress (Carnevali et al., 2003). It is also evident that lung 
Serum level (µmol/L)* Lung cancer Smoker control Level of significance 
Vitamin E 15.67 ± 3.67 14.66 ± 3.88 P=0.635 
Vitamin C 48.26 ± 6.81 16.65 ± 4.46 P=0.000 
Vitamin A 2.76 ± 0.32 1.60 ± 0.35 P=0.000 
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cancer is more prevalent among heavy smokers than the non-heavy smokers 
(Kumagai et al., 1998). Antioxidants vitamins including β-carotene have 
been reported to reduce oxidative stress. They are inversely associated with 
the risk of development of various cancers, even could cure cancer (Ocké et 
al., 1997, Lotan, 1999, Padayatty et al., 2006, Hickey et al., 2008, Chen et 
al., 2008).  This study has made an attempt to address serum vitamin E, C 
and A in lung cancer patients in comparison with those in the smokers. 
Results showed that there had no significant change in the serum 
vitamin E level between the lung cancer patients and the smokers. This 
finding is to some extent consistent with the report that serum antioxidant 
vitamins are not associated with risk of cancers (Katsoulis et al., 2007,  Emri 
et al., 2012). There is overwhelming evidence that a high intake of vitamin C 
correlates with a low risk for cancer (Block, 1991).  Vitamin C is the 
strongest antioxidant, mopping up the dangerous free radicals. It has been 
used as a dietary supplement intended to prevent oxidative stress–mediated 
chronic diseases including cancer. Vitamin C helps prevent and treat cancer 
by enhancing the immune system; stimulating the formation of collagen 
necessary for ‘walling off’ tumours; preventing metastasis by inhibiting a 
particular enzyme and thus keeping the ground substance around tumours 
intact; preventing viruses causing cancer; correcting a vitamin C deficiency 
in cancer patients; enhancing the effectiveness and reducing the toxicity of 
some chemotherapy and  preventing free radical damage and neutralising 
some carcinogens.  Mega doses of vitamin C could cure cancer (Chen et al., 
2005, 2008). Cancer cells cannot survive in vitamin C rich environment. It is 
reported that vitamin C as an antioxidant reduces systemic oxidative stress, 
but as pro-oxidant selectively induces local oxidative stress in cancer cells 
and thus kills the cancer cells (Verrax et al., 2009). The vitamin C 
supplementation and high intake of fruits rich in vitamin C and carotenes 
would be the possible causes for higher serum vitamin C and A levels in sera 
of the lung cancer patients.   Lower serum levels of vitamin C and A in the 
smokers may be because of oxidative stress induced by tobacco smoking 
(Carnevali et al., 2003, Aoshiba, 2003). 
 
Conclusion 
Serum vitamin E value among the study population did not alter, 
which was within normal range. However, serum concentrations of vitamin 
C and A in the lung cancer patients were significantly high as compared to 
those in the smoker controls.  
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